176.71
price up icon2.72%   4.46
 
loading
Schlusskurs vom Vortag:
$172.25
Offen:
$172.21
24-Stunden-Volumen:
1.47M
Relative Volume:
0.51
Marktkapitalisierung:
$49.98B
Einnahmen:
$20.87B
Nettoeinkommen (Verlust:
$1.50B
KGV:
33.72
EPS:
5.24
Netto-Cashflow:
$2.59B
1W Leistung:
+3.12%
1M Leistung:
+2.51%
6M Leistung:
-22.01%
1J Leistung:
-22.83%
1-Tages-Spanne:
Value
$171.32
$179.12
1-Wochen-Bereich:
Value
$168.89
$179.12
52-Wochen-Spanne:
Value
$163.33
$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Name
Firmenname
Becton Dickinson Co
Name
Telefon
(201) 847-6800
Name
Adresse
ONE BECTON DR, FRANKLIN LAKES
Name
Mitarbeiter
74,000
Name
Twitter
@BDandCo
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
BDX's Discussions on Twitter

Vergleichen Sie BDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
176.71 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
536.30 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.02 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
256.31 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
222.32 16.36B 2.90B 467.20M 306.90M 6.37

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-22 Herabstufung Citigroup Buy → Neutral
2025-05-02 Herabstufung Goldman Buy → Neutral
2025-05-02 Herabstufung Piper Sandler Overweight → Neutral
2025-05-02 Herabstufung Raymond James Outperform → Mkt Perform
2025-05-01 Herabstufung BofA Securities Buy → Neutral
2025-05-01 Herabstufung Wells Fargo Overweight → Equal Weight
2025-05-01 Herabstufung William Blair Outperform → Mkt Perform
2024-10-01 Hochstufung Citigroup Neutral → Buy
2024-05-30 Eingeleitet Goldman Buy
2023-07-24 Hochstufung Raymond James Mkt Perform → Outperform
2023-05-30 Fortgesetzt Morgan Stanley Overweight
2023-05-05 Hochstufung Piper Sandler Neutral → Overweight
2023-04-12 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2023-01-03 Hochstufung BofA Securities Neutral → Buy
2022-12-12 Hochstufung Citigroup Sell → Neutral
2022-07-11 Herabstufung Citigroup Neutral → Sell
2022-06-24 Hochstufung Wells Fargo Equal Weight → Overweight
2022-03-18 Fortgesetzt Raymond James Mkt Perform
2022-03-02 Fortgesetzt BofA Securities Neutral
2021-12-08 Herabstufung Piper Sandler Overweight → Neutral
2021-08-06 Herabstufung JP Morgan Overweight → Neutral
2021-05-25 Eingeleitet Barclays Equal Weight
2020-12-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-12-15 Herabstufung Wells Fargo Overweight → Equal Weight
2020-07-09 Hochstufung Barclays Equal Weight → Overweight
2020-06-01 Fortgesetzt Goldman Buy
2020-03-05 Eingeleitet Citigroup Neutral
2020-02-07 Herabstufung Cowen Outperform → Market Perform
2020-02-07 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2020-02-07 Herabstufung Raymond James Strong Buy → Outperform
2020-02-06 Herabstufung Cowen Outperform → Market Perform
2020-01-08 Herabstufung Barclays Overweight → Equal Weight
2019-05-13 Hochstufung Barclays Equal Weight → Overweight
2018-12-07 Eingeleitet Deutsche Bank Buy
2018-10-16 Eingeleitet Barclays Equal Weight
2018-06-21 Hochstufung JP Morgan Neutral → Overweight
2018-04-10 Hochstufung Citigroup Neutral → Buy
2018-01-19 Fortgesetzt BofA/Merrill Buy
2018-01-05 Hochstufung Citigroup Sell → Neutral
2018-01-05 Eingeleitet KeyBanc Capital Mkts Overweight
2018-01-03 Eingeleitet Evercore ISI Outperform
2017-12-29 Bestätigt Deutsche Bank Buy
Alle ansehen

Becton Dickinson Co Aktie (BDX) Neueste Nachrichten

pulisher
Jun 18, 2025

YieldBoost Becton, Dickinson From 2.5% To 15.5% Using Options - Nasdaq

Jun 18, 2025
pulisher
Jun 16, 2025

BD upgrades laboratory in Suzhou - China Daily

Jun 16, 2025
pulisher
Jun 14, 2025

Becton Dickinson’s SWOT analysis: medical giant’s stock faces pivotal shift - Investing.com

Jun 14, 2025
pulisher
Jun 14, 2025

Becton Dickinson’s SWOT analysis: medical giant’s stock faces pivotal shift By Investing.com - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

Becton Dickinson Stock Price, Quotes and Forecasts | NYSE:BDX - Benzinga

Jun 13, 2025
pulisher
Jun 11, 2025

Medical technology firm BD looks to bring products to more PHL hospitals - BusinessWorld Online

Jun 11, 2025
pulisher
Jun 09, 2025

Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Becton, Dickinson And Co To Present At Goldman Sachs Conference; Webcast At 2:00 PM ET - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Stifel maintains Becton Dickinson stock with a $224 target - Investing.com

Jun 09, 2025
pulisher
Jun 08, 2025

Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock - Yahoo Finance

Jun 08, 2025
pulisher
Jun 06, 2025

Barclays Lowers Becton, Dickinson & Co. (BDX) Price Target, Maintains Overweight Rating - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.

Jun 06, 2025
pulisher
Jun 05, 2025

BD’s Future Plans: Shed Life Sciences to Fund Medical Technology - Lab Manager

Jun 05, 2025
pulisher
Jun 05, 2025

How Is Becton, Dickinson and Company’s Performance Compared to Other Medical Instruments & Supplies Stocks? - Barchart.com

Jun 05, 2025
pulisher
Jun 03, 2025

Becton Dickinson (BDX) Maintains Overweight Rating Despite Price Target Cut | BDX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Barclays lowers Becton Dickinson stock price target to $241 By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

Barclays Adjusts Price Target on Becton, Dickinson and Company to $241 From $261 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Barclays lowers Becton Dickinson stock price target to $241 - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson (BDX) Receives Adjusted Price Target from Barcl - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson and : BD Vascular Access Management Recognized with Seal of Approval from Infusion Nurses Society - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson (BDX) Receives Adjusted Price Target from Barclays | BDX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson EVP David Shan Sells Shares and Other Important Updates - TradingView

Jun 03, 2025
pulisher
Jun 02, 2025

Insider Sell: David Shan Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus

Jun 02, 2025
pulisher
May 28, 2025

BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Becton, Dickinson and Company to Initiate Real-World Patient Data Registry for the Rotarex?? Atherectomy System in Treatment of Peripheral Artery Disease - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease - Becton Dickinson

May 28, 2025
pulisher
May 27, 2025

Becton Dickinson’s SWOT analysis: stock’s future hangs on life sciences spin-off - Investing.com

May 27, 2025
pulisher
May 27, 2025

Saudi Arabia Research Antibodies Market Report 2025-2030, - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Saudi Arabia Research Antibodies Market Report 2025-2030, Competitive Analysis of Cell Signaling Technology, Salima Trading, AJ Jeel Medical & Trading Co, Becton, Dickinson and Co, and Merck - Yahoo Finance

May 27, 2025
pulisher
May 25, 2025

AC Health, Becton Dickinson team up to elevate healthcare standards across Asia - Bilyonaryo Business News

May 25, 2025
pulisher
May 22, 2025

Becton Dickinson stock rating cut by Citi to Neutral, target to $185 - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Becton, Dickinson & Co (BDX) Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 22, 2025
pulisher
May 22, 2025

Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Receives Downgrade and Price Target Cut b - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Receives Downgrade and Price Target Cut by Citigroup | BDX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

6 Analysts Have This To Say About Becton Dickinson - Benzinga

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Downgraded by Citi to Neutral | BDX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Downgraded by Citi Amid Quarterly Challen - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Downgraded by Citi Amid Quarterly Challenges | BDX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citigroup Downgrades Becton Dickinson and Co. to Neutral From Buy, Adjusts PT to $185 From $217 - marketscreener.com

May 22, 2025
pulisher
May 21, 2025

BD aims to secure slice of medical technology market - BusinessMirror

May 21, 2025
pulisher
May 21, 2025

Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs' - BD Newsroom

May 21, 2025
pulisher
May 19, 2025

Employees return to work at North Canaan plant where suspicious package was delivered, officials say - CT Insider

May 19, 2025
pulisher
May 16, 2025

FBI probes North Canaan suspicious package that contaminated hundreds: What we know and don't know - CT Insider

May 16, 2025
pulisher
May 16, 2025

Becton, Dickinson and Company Stock: Analyst Estimates & Ratings - inkl

May 16, 2025
pulisher
May 15, 2025

Becton, Dickinson and Company (BDX): Among the Most Oversold Stocks to Buy According to Billionaires - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

Health dept. clears BD to reopen facility after hazmat scare - The Lakeville Journal

May 15, 2025
pulisher
May 15, 2025

Argus Adjusts Price Target on Becton Dickinson and Co. to $220 From $270, Maintains Buy Rating - marketscreener.com

May 15, 2025

Finanzdaten der Becton Dickinson Co-Aktie (BDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies ALC
$88.95
price up icon 0.65%
medical_instruments_supplies RMD
$256.39
price down icon 0.72%
medical_instruments_supplies WST
$222.20
price up icon 1.49%
medical_instruments_supplies BAX
$31.07
price up icon 2.61%
$65.62
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):